Skip to main content
main-content

Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes

06-16-2018 | Hypoglycemia | Slideset | Gallery

FreeStyle Libre: a collection of summaries from key clinical trials

This slide set outlines the extension phase of the REPLACE trial, which shows that the significant reductions in hypoglycemia obtained in patients with insulin-dependent type 2 diabetes after 6 months of flash glucose monitoring use were sustained over an additional 6 months.

Read the full-text article here

Funded by an educational grant from Abbott Diabetes Care

06-11-2018 | Download | PPTX 319.8 KB

Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes

Download
Image Credits